-
EP2699552
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP2699552
| EP2699552 - MULTICOMPONENT CRYSTALLINE SYSTEM OF ROSUVASTATIN CALCIUM SALT AND VANILLIN [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 25.11.2016 Database last updated on 19.10.2024 | Most recent event Tooltip | 25.11.2016 | Change or deletion - application deemed withdrawn | published on 28.12.2016 [2016/52] | Applicant(s) | For all designated states BASF SE Carl-Bosch-Strasse 38 67056 Ludwigshafen am Rhein / DE | [N/P] |
| Former [2014/09] | For all designated states BASF SE 67056 Ludwigshafen / DE | Inventor(s) | 01 /
HAFNER, Andreas Balkenweg 23 CH-4460 Gelterkinden / CH | 02 /
BLATTER, Fritz Oerinstrasse 67 CH-4153 Reinach / CH | 03 /
SZELAGIEWICZ, Martin Christoph Merian Strasse 1 CH-4142 Münchenstein / CH | 04 /
SIEBENHAAR, Bernd Obere Dorfstrasse 18 79400 Kandern-Wollbach / DE | [2014/09] | Representative(s) | Upschulte, Manfred Alois BASF Schweiz AG IP Department Postfach 4002 Basel / CH | [2014/09] | Application number, filing date | 12714011.9 | 16.04.2012 | WO2012EP56863 | Priority number, date | US201161476334P | 18.04.2011 Original published format: US 201161476334 P | EP20110162801 | 18.04.2011 Original published format: EP 11162801 | [2014/09] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2012143308 | Date: | 26.10.2012 | Language: | EN | [2012/43] | Type: | A1 Application with search report | No.: | EP2699552 | Date: | 26.02.2014 | Language: | EN | The application published by WIPO in one of the EPO official languages on 26.10.2012 takes the place of the publication of the European patent application. | [2014/09] | Search report(s) | International search report - published on: | EP | 26.10.2012 | Classification | IPC: | C07D239/42, A61K31/505, A61P9/00 | [2014/09] | CPC: |
C07D239/42 (EP,US);
A61K31/505 (US);
A61K31/11 (US);
A61K47/10 (US);
A61P9/00 (EP)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2014/09] | Title | German: | KRISTALLINES MULTIKOMPONENTENSYSTEM AUS ROSUVASTATIN-CALCIUMSALZ UND VANILLIN | [2014/09] | English: | MULTICOMPONENT CRYSTALLINE SYSTEM OF ROSUVASTATIN CALCIUM SALT AND VANILLIN | [2014/09] | French: | SYSTÈME CRISTALLIN À MULTIPLES CONSTITUANTS CONSTITUÉ DE SEL DE CALCIUM DE ROSUVASTATINE ET DE VANILLINE | [2014/09] | Entry into regional phase | 18.11.2013 | National basic fee paid | 18.11.2013 | Designation fee(s) paid | 18.11.2013 | Examination fee paid | Examination procedure | 18.11.2013 | Examination requested [2014/09] | 02.06.2014 | Amendment by applicant (claims and/or description) | 14.08.2014 | Despatch of a communication from the examining division (Time limit: M04) | 03.01.2015 | Application deemed to be withdrawn, date of legal effect [2015/27] | 06.01.2015 | Application deemed to be withdrawn, date of legal effect [2016/52] | 23.01.2015 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2016/52] | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 14.08.2014 | Fees paid | Renewal fee | 31.03.2014 | Renewal fee patent year 03 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [AD]WO0042024 (ASTRAZENECA UK LTD [GB], et al) [AD] 1-15* the whole document *; | [AD]WO2006079611 (CIBA SC HOLDING AG [CH], et al) [AD] 1-15 * the whole document *; | [AD]WO2008036286 (TEVA PHARMA [IL], et al) [AD] 1-15 * the whole document * | by applicant | WO0042024 | EP1663989 | WO2006079611 | US2008176878 | - JOURNAL OF PHARMACEUTICAL SCIENCES, (2007), vol. 96, pages 2390 - 2398 |